Not everyone needs — or tolerates — a full dose.
Low-dose GLP-1 therapy, often called "microdosing," uses smaller, individualized amounts to support appetite regulation, metabolic health, and long-term weight maintenance — with fewer side effects for many patients.
At The Optime Studio, your dose is determined by your provider based on your goals and response — not a generic protocol — and monitored closely over time.
See If You Qualify
Gentle progress. Lasting results.
Your protocol. Your pace.
Your dose is set by a clinician,
not an algorithm.
Gabrielle Mount Borrero, a board-certified nurse practitioner with 15+ years of clinical experience, evaluates your full metabolic picture before determining your starting dose — and adjusts it as your body responds.
Why microdosing works differently
Standard GLP-1 titration schedules are designed for maximum weight loss velocity — not for every body. Microdosing takes a different approach: sub-threshold doses allow your central nervous system and GI tract to adapt gradually, preserving the metabolic benefits while dramatically reducing the side effects that cause most patients to stop.
Metabolic flexibility
Lower doses maintain insulin sensitivity and glucagon suppression without the aggressive caloric restriction that triggers muscle catabolism — protecting lean tissue while the body adapts.
Receptor sensitivity management
Gradual titration prevents GLP-1 receptor downregulation, keeping the medication effective over longer periods and reducing the dose escalation cycle common with standard protocols.
GI tolerance
Nausea, constipation, and early satiety are dose-dependent. Microdosing keeps plasma levels below the threshold that triggers severe GI side effects while still reducing food noise and appetite.
Lean tissue preservation
Rapid weight loss at standard doses can accelerate muscle mass loss. Slower, controlled metabolic shifts at microdose levels allow the body to preferentially mobilize fat stores.
Compounded GLP-1 — clinical cost stability when brand-name coverage fails
Brand-name GLP-1 medications like Ozempic and Wegovy face frequent insurance denials, prior authorization delays, and supply shortages across Palm Beach and Broward counties. Our compounding pharmacy partnerships provide clinically equivalent semaglutide and tirzepatide at predictable, transparent pricing — so your protocol never stalls because of a coverage gap.
All compounded medications are sourced from FDA-registered 503B outsourcing facilities and dispensed under direct provider supervision.
Frequently Asked
Individual results may vary. Services provide clinical care and oversight only; medications and labs billed separately. Not a substitute for primary or emergency care.